Immuneering (IMRX) Amortization - Intangibles (2022 - 2026)
Immuneering (IMRX) posted quarterly Amortization - Intangibles of $7317.0 for Q1 2026, little changed year-over-year from $7317.0 in Q1 2025, and little changed quarter-over-quarter from $7317.0 in Q4 2025.
Powered by 
Analysis
Immuneering (IMRX) Amortization - Intangibles (2022 - 2026) Analysis & Trends
Immuneering's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $7317.0 for Q1 2026.
- In Q1 2026, Amortization - Intangibles changed 0.0% year-over-year to $7317.0; the TTM figure through Mar 2026 stood at $29268.0 (changed 0.0% YoY), while the FY2025 annual figure was $29267.0, changed 0.0% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $7317.0, roughly flat from $7317.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $8103.0 in Q1 2022, with the low at $7316.0 in Q4 2022.
- The 5-year median for Amortization - Intangibles is $7317.0 (2022), against an average of $7363.2.
- Peak annual rise in Amortization - Intangibles reached 0.01% in 2023, while the deepest fall reached 9.7% in 2023.
- Immuneering's Amortization - Intangibles stood at $7316.0 in 2022, then rose by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
- Business Quant data shows IMRX's Amortization - Intangibles at $7317.0 in Q1 2026, $7317.0 in Q4 2025, and $7317.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Immuneering | 316.05 Mn | 316.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,317.00 |
| Mar 31, 2026 | 7,317.00 |
| Dec 31, 2025 | 7,317.00 |
| Sep 30, 2025 | 7,317.00 |
| Jun 30, 2025 | 7,317.00 |
| Mar 31, 2025 | 7,317.00 |
| Dec 31, 2024 | 7,317.00 |
| Sep 30, 2024 | 7,317.00 |
| Jun 30, 2024 | 7,317.00 |
| Mar 31, 2024 | 7,317.00 |
| Dec 31, 2023 | 7,317.00 |
| Sep 30, 2023 | 7,317.00 |
| Jun 30, 2023 | 7,317.00 |
| Mar 31, 2023 | 7,317.00 |
| Dec 31, 2022 | 7,316.00 |
| Sep 30, 2022 | 7,317.00 |
| Jun 30, 2022 | 7,317.00 |
| Mar 31, 2022 | 8,103.00 |